Skip to Main Content

Christopher Tinkle, MD, PhD

Associate Member, St. Jude Faculty

On this page:

Contact Information

Christopher Tinkle, MD, PhD

Radiation Oncology

MS 210, Room I3124

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 38105-3678

Education

BA – University of Texas at Austin, Austin, Texas PhD – Rockefeller University, New York, New York MD – Weill Cornell Medical College, New York, New York Transitional Internship – University of Texas Southwestern, Austin Programs, Austin, Texas Residency (Radiation Oncology) – University of California, San Francisco, San Francisco, California

Honors & Awards

  • 2015 Roentgen Resident/Fellow Award Recipient
  • 2013 ASTRO Annual Meeting Scientific Abstract/Travel Award
  • 2013 Mount Zion Health Fund Travel Award, UCSF
  • 2012 UCSF Clinical and Translational Science Institute Resident Research Funding Award
  • 2012-2014 Resident Research Travel Award, UCSF

Research Interests

  • Reduction of treatment-associated morbidity of children and adolescents with cancer
  • Cancer initiation and disease progression
  • Treatment resistance
  • Therapy-related toxicity
  • Brain tumors and sarcomas 

Clinical Trials

Recruiting
NRSTS2021: A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy, and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma

Study goal:

The purpose of this clinical trial is to find better treatments for NRSTS patients who are intermediate- and high-risk. Our goal is to lower the risk of the tumor coming back after treatment, while using treatments with fewer risks of long-term side effects.

Age:

Up to 30 years old.

Dr. Tinkle in Progress

St. Jude Publications